Neurocrine Biosciences | Zapasy



Stock Zmiana Data
AbbVie USD 4.18B 269M 2024-12
Acadia Pharmaceuticals USD 21.95M 39.09M 2024-12
Agios Pharmaceuticals USD 27.62M 1.19M 2024-12
ALKERMES USD 182.89M 8.2M 2024-12
Alnylam Pharmaceuticals USD 78.51M 2.52M 2024-12
Amgen USD 7B 364M 2024-12
Biogen USD 2.46B 8.7M 2024-12
BioMarin Pharmaceutical USD 1.23B 53.31M 2024-12
Cytokinetics 0 0 2023-12
Dynavax Technologies USD 70.05M 7.65M 2024-12
Exelixis USD 22.39M 1.38M 2024-12
Gilead Sciences USD 3.59B 154M 2024-12
Halozyme Therapeutics USD 141.86M 10.45M 2024-12
Incyte USD 58.87M 11.57M 2024-12
Intra Cellular Therapies USD 26.28M 2.74M 2024-12
Ionis Pharmaceuticals USD 12.51M 15.94M 2024-12
Neurocrine Biosciences USD 57.4M 11.6M 2024-12
Pfizer USD 10.85B 870M 2024-12
Regeneron Pharmaceuticals USD 3.09B 69.3M 2024-12
Repligen USD 182.46M 8.06M 2024-09
Sarepta Therapeutics USD 749.96M 184.04M 2024-12
Teva Pharmaceutical Industries USD 3.01B 952M 2024-12
Ultragenyx Pharmaceutical USD 45.01M 1.67M 2024-12
Vertex Pharmaceuticals USD 1.21B 125.6M 2024-12



Neurocrine Biosciences Zapasy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.